HIV-1 infection is facilitated in T cells by decreasing p56lck protein tyrosine kinase activity

Clinical and Experimental Immunology

Volumn 133, Issue 1, 2003, Pages 78-90

  Yousefi, S ^a   Ma, X Z ^a,b   Singla, R ^d   Zhou, Y C ^b   Sakac, D ^c   Bali, M ^b   Liu, Y ^a,c   Sahai, B M ^d   Branch, Donald R ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

AIDS; HIV 1; Lck; T lymphocytes; Tyrosine kinases

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CD4 ANTIGEN; COMPLEMENTARY DNA; CYSTEINE; DNA; METHIONINE; PROTEIN P56; PROTEIN TYROSINE KINASE; SULFUR 35;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS INFECTION;

ANTIGENS, CD4; ANTIGENS, CD45; CELL DIVISION; ENZYME ACTIVATION; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; INTERLEUKIN-16; JURKAT CELLS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); OLIGONUCLEOTIDES, ANTISENSE; RECEPTORS, CXCR4; T-LYMPHOCYTES; TIME FACTORS; VIRUS REPLICATION;

EID: 0038385438     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2003.02187.x     Document Type: Article

References (63)

1. Pinching AJ, Nye KE. Defective signal transduction - a common pathway for cellular dysfunction in HIV infection? Immunol Today 1990; 11:256-9.
2. Broder CC, Berger EA. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion. J Virol 1993; 67:913-26.
3. Straus DB, Weiss A. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 1992; 70:585-93.
4. Glaichenhaus N, Shastri N, Littman DR, Turner JM. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell 1991; 64:511-20.
5. Horak ID, Gress RE, Lucas PJ, Horak EM, Waldmann TA, Bolen JB. T-lymphocyte interleukin 2-dependent tyrosine protein kinase signal transduction involves the activation of p56lck. Proc Natl Acad Sci USA 1991; 88:1996-2000.
6. lck with cytoplasmic domains of CD4 and CD8 is mediated by cysteine motifs. Cell 1990; 60:755-65.
7. lck. Cell 1988; 55:301-8.
8. Mustelin T, Burn P. Regulation of src family tyrosine kinases in lymphocytes. Trends Biochem Sci 1993; 18:215-20.
9. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor. functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-7.
10. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, Berger EA. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955-8.
11. Unutmaz D, Littman DR. Expression pattern of HIV-1 coreceptors on T-cells: implications for viral transmission and lymphocyte homing. Proc Natl Acad Sci USA 1997; 94:1615-8.
12. Phipps DJ, Reed-Doob P, Macfadden DK, Piovesan JP, Mills GB, Branch DR. An octapeptide analogue of HIV gp120 modulates protein tyrosine kinase activity in activated peripheral blood T lymphocytes. Clin Exp Immunol 1995; 100:412-8.
13. Phipps DJ, Read SE, Piovesan JP, Mills GB, Branch DR. HIV infection in vitro enhances the activity of src-family protein tyrosine kinases. AIDS 1996; 10:1191-8.
14. Phipps DJ, Yousefi S, Branch DR. Increased enzymatic activity of the T-cell antigen receptor-associated fyn protein tyrosine kinase in asymptomatic patients infected with the human immunodeficiency virus. Blood 1997; 90:3603-12.
15. Cohen DI, Tani Y, Tian H, Boone E, Samelson LE, Lane HC. Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1. Science 1992; 256:542-5.
16. lck in human CD4 T lymphocytes. Eur J Immunol 1993; 23:600-7.
17. Stefanova I, Saville MW, Peters C et al. HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest 1996; 98:1290-7.
18. Benkirane M, Jeang KT, Devaux C. The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T-cells. EMBO J 1994; 13:5559-69.
19. Benkirane M, Schmid-Antomarchi H, Littman DR, Hirn M, Rossi B, Devaux C. The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin CDR3-like region in domain 1 of CD4. J Virol 1995; 69:6904-10.
20. lck. J Exp Med 1996; 183:39-48.
21. lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J 1994; 13:774-83.
22. Koretzky GA, Picus J, Schultz T, Weiss A. Tyrosine phosphatase CD45 is required for T-cell antigen receptor and CD2-mediated activation of a protein tyrosine kinase and interleukin 2 production. Proc Natl Acad Sci USA 1991; 88:2037-41.
23. Mills GB, Arima N, May C, Hill M, Schmandt R, Li J, Miyamoto NG, Greene WC. Neither the LCK nor the FYN kinases are obligatory for IL-2-mediated signal transduction in HTLV-I-infected human T cells. Int Immunol 1992; 4:1233-43.
24. Abraham N, Miceli MC, Parnes JR, Veillette A. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature 1991; 350:62-6.
25. Branch DR, Valenta LJE, Yousefi S, Sakac D, Singla R, Bali M, Sahai BM, Ma XZ. VPAC1 is a cellular neuroendocrine receptor expressed on T cells that actively facilitates productive HIV-1 infection. AIDS 2002; 16:309-19.
26. Branch DR, Guilbert LJ. Differential expression of tumor necrosis factor-alpha isoforms from lipopolysaccharide- and cytokine-stimulated mouse macrophages. Int J Biochem Cell Biol 1996; 28:949-55.
27. c-src expression is induced by activation of normal human T lymphocytes. J Immunol 1995; 154:3678-85.
28. Cooper JA, Hunter T. Identification and characterization of cellular targets for tyrosine protein kinases. J Biol Chem 1983; 258:1108-15.
29. Levy-Mintz P, Duan L, Zhang H et al. Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol 1996; 70:8821-32.
30. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen ISY. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990; 61:213-22.
31. Abbott MA, Poiesz BJ, Byrne BC, Kwok S, Sninsky JJ, Ehrlich GD. Enzymatic gene amplification, qualitative and quantitative methods for detecting proviral DNA amplified in vitro. J Infect Dis 1988; 158:1158-69.
32. Gratzl S, Moroni C, Hirsch HH. Quantification of HIV-1 viral RNA and proviral DNA by isotopic competitive PCR. J Virol Meth 1997; 66:269-82.
33. Hurley TR, Hyman R, Sefton BM. Differential effects of expression of the CD45 tyrosine protein phosphatase on the tyrosine phosphorylation of the lck, fyn, and c-src tyrosine protein kinases. Mol Cell Biol 1993; 13:1651-6.
34. Burns CM, Sakaguchi K, Appella E, Ashwell JD. CD45 regulation of tyrosine phosphorylation and enzyme activity of src family kinases. J Biol Chem 1994; 269:13594-600.
35. Duplay P, Alcover A, Fargeas C, Sekaly RP, Branton PE. An activated epidermal growth factor receptor/Lck chimera restores early T cell receptor-mediated calcium response in a CD45-deficient T cell line. J Biol Chem 1996; 271:17896-902.
36. D'Oro U, Sakaguchi K, Appella E, Ashwell JD. Mutational analysis of Lck in CD45-negative T cells: dominant role of tyrosine 394 phosphorylation in kinase activity. Mol Cell Biol 1996; 16:4996-5003.
37. D'Oro U, Ashwell JD. Cutting edge. the CD45 tyrosine phosphatase is an inhibitor of Lck activity in thymocytes. J Immunol 1999; 162:1879-83.
38. Ashwell JD, D'Oro U. CD45 and Src-family kinases: and now for something completely different. Immunol Today 1999; 20:412-6.
39. Greenway A, Azad A, Mills J, McPhee D. Human immunodeficiency virus type 1 Nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. J Virol 1996; 70:6701-8.
40. Collette Y, Dutartre H, Benziane A. Ramos-Morales, Benarous R, Harris M, Olive D. Physical and functional interaction of Nef with Lck. HIV-1 Nef-induced T-cell signaling defects. J Biol Chem 1996; 271:6333-41.
41. Sakaki Y, Terashi K, Yamaguchi A et al. Human T-cell lymphotropic virus type I Tax activates lung resistance-related protein expression in leukemic clones established from an adult T-cell leukemia patient. Exp Hematol 2002; 30:340-5.
42. Guilbert LJ, Winkler-Lowen B, Smith A, Branch DR, Garcia-Lloret M. Analysis of the synergistic stimulation of mouse macrophage proliferation by macrophage colony-stimulating factor (CSF-1) and tumor necrosis factor alpha (TNF-alpha). J Leuko Biol 1993; 54:65-72.
43. Bukrinsky M, Sharova N, Stevenson M. Human immunodeficiency virus type 1 2-LTR circles reside in a nucleoprotein complex which is different from the preintegration complex. J Virol 1993; 67:6863-5.
44. Engelman A, Englund G, Orenstein JM, Martin MA, Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J Virol 1995; 69:2729-36.
45. Matsukura M, Shinozuka K, Zon G, Mitsuya H, Reitz M, Cohen JS, Broder S. Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. Proc Natl Acad Sci USA 1987; 84:7706-10.
46. Stein CA, Neckers LM, Nair BC, Mumbauer S, Hoke G, Pal R. Phosphorothioate oligodeoxycytidine interferes with binding of HIV-1 gp120 to CD4. J Acq Immune Def Synd 1991; 4:686-93.
47. Yang WC, Olive D. Tec kinase is involved in transcriptional regulation of IL-2 and IL-4 in the CD28 pathway. Eur J Immunol 1999; 29:1842-9.
48. Center DM, Berman JS, Kornfeld H, Theodore AC, Cruikshank WW. The lymphocyte chemoattractant factor. J Laboratory Clin Med 1995; 125:167-72.
49. Ryan TC, Cruikshank WW, Kornfeld H, Collins TL, Center DM. The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration. J Biol Chem 1995; 270:17081-6.
50. Baier M, Werner A, Bannert N, Metzner K, Kurth R. HIV suppression by interleukin-16. Nature 1995; 378:563.
51. Zhou P, Goldstein S, Devadas K, Tewari D, Notkins AL. Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nat Med 1997; 3:659-64.
52. Maciaszek JW, Parada NA, Cruikshank WW, Center DM, Kornfeld H, Viglianti GA. IL-16 represses HIV-1 promoter activity. J Immunol 1997; 158:5-8.
53. Briand G, Barbeau B, Corbeil J, Tremblay M. Enhancement of HIV-1-induced syncytium formation in T cells by the tyrosyl kinase p56lck. Virology 1997; 231:10-9.
54. Collette Y, Olive D. Non-receptor protein tyrosine kinases as immune targets of viruses. Immunol Today 1997; 18:393-400.
55. Stevenson M, Haggerty S, Lamonica CA, Meir CM, Welch SK, Wasiak AJ. HIV-1 replication is controlled at the level of T cell activation and proviral integration. J Virol 1990; 64:2421-5.
56. Cheng H, Hoxie JP, Parks WP. The conserved core of human immunodeficiency virus type 1 Nef is essential for association with Lck and for enhanced viral replication in T-lymphocytes. Virology 1999; 264:5-15.
57. Guntermann C, Dye J, Nye KE. Human immunodeficiency virus infection abolishes CD4-dependent activation of ZAP-70 by inhibition of p56lck. J Acquit Immune Defic Syndr Hum Retrovirol 1997; 14:201-12.
58. Harouse JM, Kunsch C, Harle HT et al. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol 1989; 63:2527-33.
59. Fantini J, Cook DG, Nathanson N et al. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus (HIV-1) is associated with cell surface expression of glactosyl ceramide, a potential alternative gp 120 receptor. Proc Natl Acad Sci USA 1993; 90:2700-4.
60. Briand G, Barbeau B, Tremlay M. Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proreins, including the phosphatidylinositol 3-kinase. Virology 1997; 228:171-9.
61. Popik W, Pitha PM. Binding of human immunodeficiency virus type 1 to CD4 induces association of Lck and Raf-1 and activates Raf-1 by a Ras-independent pathway. Mol Cell Biol 1996; 16:6532-41.
62. Lorenz U, Ravichandran KS, Burakoff SJ, Neel BG. Lack of SHPTP1 results in src-family kinase hyperactivation and thymocyte hyperreponsiveness. Proc Natl Acad Sci USA 1996; 93:9624-9.
63. Hill CM, Littman DR. Natural resistance to HIV? Nature 1996; 382:668-9.